Ajanta Pharma Ltd
NSE: AJANTPHARM BSE: 532331
₹3048.20
(1.61%)
Thu, 19 Mar 2026, 02:52 pm
Market Cap374.81B
PE Ratio37.54
Dividend0.93
Health Technology
Pharmaceuticals: Major
24.5KCompany History
2005
- Max Healthcare established India's first brain lab in New Delhi.
- Max India Ltd and Max Telecom Ventures Ltd signed a MoU.
2008
- Max India signed an agreement with a UK firm for health insurance business.
2012
- The Board declared an Interim Dividend of 500%, i.e., Rs 10 for every equity share of Rs 2 each to the shareholders.
- Ajanta Pharma split its face value from Rs 10 to Rs 5.
2013
- The Board recommended a Final Dividend of 610%, amounting to Rs 12.20 per equity share of Rs 2 each to the shareholders.
- Ajanta Pharma announced a bonus in the ratio of 1:2.
2014
- The Board recommended a Final Dividend of 90%, i.e., Rs 1.80 for every equity share of Rs 2 each to the shareholders.
2015
- Ajanta Pharma announced the launch of Montelukast Sodium Oral Granules.
- Ajanta Pharma launched Montelukast IR Tablets and Montelukast Chewable Tablets in the US market.
- Ajanta Pharma received an award from Fortune India.
- Ajanta Pharma got approvals for 3 ANDA's.
- Ajanta Pharma split its face value from Rs 5 to Rs 2.
2017
- Ajanta Pharma received USFDA nod for Duloxetine Hydrochloride.
- Ajanta Pharma launched Eletriptan Hydrobromide Tablets.
- Ajanta Pharma launched Clonidine Hydrochloride Extended Release Tablets in the US.
- The 1st phase at a new facility in Guwahati, Assam, India was inaugurated and commissioned.
- The Dahej facility received successful US FDA approval.
2018
- Ajanta Pharma received the Top Export Performer Award by the Federation of Indian Export Organisations.
- Ajanta's 1st ever Derma facility was commissioned in Guwahati.
2019
- Ajanta Pharma USA Inc received the DIANA award for Best Overall Generic Manufacturer in less than $100 million.
- A new manufacturing facility for oral solid was inaugurated at Pithampur.
2020
- Ajanta's 1st Sterile Eye Drop Production Unit was commissioned at the Guwahati Facility.
2021
- Ajanta Pharma was listed in the Fortune 500 list of Indian companies, ranked 379th in Revenue Generation.
2022
- The Company issued Bonus Shares in the Ratio of 1:2.
- Ajanta Pharma was awarded India's Best Managed Companies for 2022 by Deloitte.
- Ajanta won the Maharashtra State Best Employer Brand Awards 2022 in the Pharma sector.
- Ajanta won Excellence in Packaging Developed in India and Packaging Team of the Year at India Packaging Awards 2022.
2023
- The Company proposed a buyback of its equity shares.
- Ajanta won the Outstanding Export Performance Award from Pharmexcil in the Formulation category.
- Ajanta won the Excellence in Pharma Supply Chain Management award.
- Ajanta won the Times Ascent Global Best Employer Brands 2023 award.
2024
- Ajanta Pharma was certified as a great place to work in India for the 2nd year.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800